Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL1729 (Alimix, Cisapride, Cisapride monohydrate, Prepulsid, Prepulsid quicklet, Propulsid, Propulsid quicksolv, R-51,619, R-51619) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
Alpha-1a adrenergic receptor in Bovine (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4892] [UniProtKB: P18130] | ||||||||
ChEMBL | Binding affinity was evaluated by Alpha-1 adrenergic receptor in calf cortex by displacing prazosin | B | 7.5 | pKd | 7.5 | - | pKD | J Med Chem (1995) 38: 2326-2330 [PMID:7608898] |
α1A-adrenoceptor/Alpha-1a adrenergic receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL319] [GtoPdb: 22] [UniProtKB: P43140] | ||||||||
ChEMBL | DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin) | B | 7.31 | pKi | 49 | nM | Ki | DrugMatrix in vitro pharmacology data |
ChEMBL | The ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brain | B | 7.52 | pKi | 30 | nM | Ki | J Med Chem (1992) 35: 1486-1489 [PMID:1573641] |
ChEMBL | DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin) | B | 6.92 | pIC50 | 120 | nM | IC50 | DrugMatrix in vitro pharmacology data |
α1B-adrenoceptor/Alpha-1b adrenergic receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL315] [GtoPdb: 23] [UniProtKB: P15823] | ||||||||
ChEMBL | DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) | B | 8.06 | pKi | 8.65 | nM | Ki | DrugMatrix in vitro pharmacology data |
ChEMBL | DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) | B | 7.8 | pIC50 | 16 | nM | IC50 | DrugMatrix in vitro pharmacology data |
α1D-adrenoceptor/Alpha-1d adrenergic receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL223] [GtoPdb: 24] [UniProtKB: P25100] | ||||||||
ChEMBL | DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) | B | 7.03 | pKi | 93 | nM | Ki | DrugMatrix in vitro pharmacology data |
ChEMBL | DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) | B | 6.72 | pIC50 | 189 | nM | IC50 | DrugMatrix in vitro pharmacology data |
α2A-adrenoceptor/Alpha-2a adrenergic receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1867] [GtoPdb: 25] [UniProtKB: P08913] | ||||||||
ChEMBL | DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) | B | 6.18 | pKi | 666 | nM | Ki | DrugMatrix in vitro pharmacology data |
ChEMBL | DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) | B | 5.75 | pIC50 | 1777 | nM | IC50 | DrugMatrix in vitro pharmacology data |
α2A-adrenoceptor/Alpha-2a adrenergic receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL327] [GtoPdb: 25] [UniProtKB: P22909] | ||||||||
ChEMBL | Compound was evaluated for the binding affinity at Alpha adrenergic receptor | B | 7.52 | pKi | 30 | nM | Ki | J Med Chem (1995) 38: 2326-2330 [PMID:7608898] |
α2B-adrenoceptor/Alpha-2b adrenergic receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1942] [GtoPdb: 26] [UniProtKB: P18089] | ||||||||
ChEMBL | DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) | B | 6.28 | pKi | 524 | nM | Ki | DrugMatrix in vitro pharmacology data |
ChEMBL | DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) | B | 5.94 | pIC50 | 1148 | nM | IC50 | DrugMatrix in vitro pharmacology data |
α2C-adrenoceptor/Alpha-2c adrenergic receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1916] [GtoPdb: 27] [UniProtKB: P18825] | ||||||||
ChEMBL | DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912) | B | 6.95 | pKi | 113 | nM | Ki | DrugMatrix in vitro pharmacology data |
ChEMBL | DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912) | B | 6.11 | pIC50 | 780 | nM | IC50 | DrugMatrix in vitro pharmacology data |
β1-adrenoceptor/Beta-1 adrenergic receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL213] [GtoPdb: 28] [UniProtKB: P08588] | ||||||||
ChEMBL | Binding affinity to adrenergic beta-1 receptor | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2006) 49: 1125-1139 [PMID:16451077] |
β2-adrenoceptor/Beta-2 adrenergic receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL210] [GtoPdb: 29] [UniProtKB: P07550] | ||||||||
ChEMBL | Binding affinity to adrenergic beta-2 receptor | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2006) 49: 1125-1139 [PMID:16451077] |
CYP2D6/Cytochrome P450 2D6 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL289] [GtoPdb: 1329] [UniProtKB: P10635] | ||||||||
ChEMBL | DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) | B | 7.15 | pIC50 | 70 | nM | IC50 | DrugMatrix in vitro pharmacology data |
CYP3A4/Cytochrome P450 3A4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL340] [GtoPdb: 1337] [UniProtKB: P08684] | ||||||||
ChEMBL | DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin) | B | 6.52 | pIC50 | 300 | nM | IC50 | DrugMatrix in vitro pharmacology data |
D1 receptor/Dopamine D1 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2056] [GtoPdb: 214] [UniProtKB: P21728] | ||||||||
ChEMBL | Binding affinity to dopamine receptor D1 | B | 5.77 | pIC50 | 1700 | nM | IC50 | J Med Chem (2006) 49: 1125-1139 [PMID:16451077] |
Dopamine D1 receptor in Bovine (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2967] [UniProtKB: Q95136] | ||||||||
ChEMBL | Binding affinity was evaluated by Dopamine receptor D1 agonism in the calf striatum by displacing SCH 23390 | B | 5.2 | pKd | 5.2 | - | pKD | J Med Chem (1995) 38: 2326-2330 [PMID:7608898] |
D1 receptor/Dopamine D1 receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL265] [GtoPdb: 214] [UniProtKB: P18901] | ||||||||
ChEMBL | The ability to inhibit [3H]-SCH- 23390 binding to Dopamine receptor D1 in rat striata | B | 5.77 | pKi | 1700 | nM | Ki | J Med Chem (1992) 35: 1486-1489 [PMID:1573641] |
D2 receptor/Dopamine D2 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL217] [GtoPdb: 215] [UniProtKB: P14416] | ||||||||
ChEMBL | DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) | B | 6.8 | pKi | 158 | nM | Ki | DrugMatrix in vitro pharmacology data |
ChEMBL | DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) | B | 6.33 | pIC50 | 473 | nM | IC50 | DrugMatrix in vitro pharmacology data |
ChEMBL | Binding affinity to dopamine receptor D2 | B | 6.64 | pIC50 | 227 | nM | IC50 | J Med Chem (2006) 49: 1125-1139 [PMID:16451077] |
Dopamine D2 receptor in Bovine (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3998] [UniProtKB: P20288] | ||||||||
ChEMBL | Binding affinity was evaluated by Dopamine receptor D2 agonism in the calf striatum by displacing spiperone | B | 6.5 | pKd | 6.5 | - | pKD | J Med Chem (1995) 38: 2326-2330 [PMID:7608898] |
D2 receptor/Dopamine D2 receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL339] [GtoPdb: 215] [UniProtKB: P61169] | ||||||||
ChEMBL | Affinity towards Dopamine receptor D2 in rat striatum using [3H]spiperone as radioligand | B | 6.64 | pKi | 227 | nM | Ki | J Med Chem (2003) 46: 702-715 [PMID:12593651] |
ChEMBL | The ability to inhibit [3H]domperidone binding to dopamine receptor D2 in rat striata | B | 6.64 | pKi | 227 | nM | Ki | J Med Chem (1992) 35: 1486-1489 [PMID:1573641] |
ChEMBL | Displacement of [3H]spiroperidol from D2 dopamine receptor | B | 6.17 | pIC50 | 680 | nM | IC50 | J Med Chem (1994) 37: 1320-1325 [PMID:8176710] |
ChEMBL | Inhibitory activity against dopamine receptor D2 by 3H ligand binding experiments. | B | 6.41 | pIC50 | 390 | nM | IC50 | J Med Chem (1991) 34: 616-624 [PMID:1995885] |
D3 receptor/Dopamine D3 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL234] [GtoPdb: 216] [UniProtKB: P35462] | ||||||||
ChEMBL | DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) | B | 7.31 | pKi | 49 | nM | Ki | DrugMatrix in vitro pharmacology data |
ChEMBL | DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) | B | 6.84 | pIC50 | 144 | nM | IC50 | DrugMatrix in vitro pharmacology data |
Kv11.1/HERG in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL240] [GtoPdb: 572] [UniProtKB: Q12809] | ||||||||
ChEMBL | DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole) | B | 6.86 | pKi | 139.4 | nM | Ki | DrugMatrix in vitro pharmacology data |
ChEMBL | Inhibition of human ERG Y652A mutant expressed in HEK293 cells by whole cell patch clamp method | B | 5.57 | pIC50 | 2690 | nM | IC50 | J Med Chem (2009) 52: 1630-1638 [PMID:19260734] |
ChEMBL | Inhibition of human ERG F656A mutant expressed in HEK293 cells by whole cell patch clamp method | B | 5.77 | pIC50 | 1710 | nM | IC50 | J Med Chem (2009) 52: 1630-1638 [PMID:19260734] |
ChEMBL | DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole) | B | 6.77 | pIC50 | 170.1 | nM | IC50 | DrugMatrix in vitro pharmacology data |
ChEMBL | Inhibition of human ERG expressed in CHO cells by Qpatch assay | B | 6.82 | pIC50 | 150 | nM | IC50 | Eur J Med Chem (2017) 127: 72-86 [PMID:28038328] |
ChEMBL | Inhibition of human ERG S624A mutant expressed in HEK293 cells by whole cell patch clamp method | B | 6.92 | pIC50 | 120 | nM | IC50 | J Med Chem (2009) 52: 1630-1638 [PMID:19260734] |
ChEMBL | Inhibition of human ERG overexpressed in CHO cells by Qpatch method | B | 7.01 | pIC50 | 98 | nM | IC50 | Bioorg Med Chem (2015) 23: 5881-5890 [PMID:26211462] |
ChEMBL | Inhibition of human ERG expressed in CHO cells by whole-cell patch clamp assay | B | 7.1 | pIC50 | 80 | nM | IC50 | J Med Chem (2014) 57: 3687-3706 [PMID:24564525] |
ChEMBL | Inhibitory activity against Potassium channel HERG | B | 7.33 | pIC50 | 47 | nM | IC50 | J Med Chem (2003) 46: 2017-2022 [PMID:12747773] |
ChEMBL | Inhibition of K+ channel activity in CHO cells expressing HERG Kv11.1 | B | 7.35 | pIC50 | 45 | nM | IC50 | Bioorg Med Chem Lett (2003) 13: 1829-1835 [PMID:12729675] |
ChEMBL | Inhibition of human ERG expressed in CHO cells assessed as whole cell current by patch clamp assay | B | 7.4 | pIC50 | 40 | nM | IC50 | J Med Chem (2015) 58: 4506-4520 [PMID:25992974] |
GtoPdb | - | - | 7.4 | pIC50 | 44.5 | nM | IC50 | FEBS Lett (1997) 417: 28-32 [PMID:9395068] |
ChEMBL | Inhibition of human Potassium channel HERG expressed in mammalian cells | B | 7.4 | pIC50 | 39.81 | nM | IC50 | Bioorg Med Chem Lett (2003) 13: 2773-2775 [PMID:12873512] |
ChEMBL | Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique | B | 7.4 | pIC50 | 39.81 | nM | IC50 | Bioorg Med Chem (2008) 16: 6252-6260 [PMID:18448342] |
ChEMBL | Inhibitory concentration against potassium channel HERG | B | 7.4 | pIC50 | 39.81 | nM | IC50 | Bioorg Med Chem Lett (2005) 15: 2886-2890 [PMID:15911273] |
ChEMBL | Inhibition of wild-type human ERG expressed in HEK293 cells by whole cell patch clamp method | B | 8 | pIC50 | 10 | nM | IC50 | J Med Chem (2009) 52: 1630-1638 [PMID:19260734] |
ChEMBL | Inhibition of human ERG | B | 8.17 | pIC50 | 6.76 | nM | IC50 | Eur J Med Chem (2011) 46: 618-630 [PMID:21185626] |
ChEMBL | Inhibition of human ERG channel | B | 8.17 | pIC50 | 6.7 | nM | IC50 | J Med Chem (2009) 52: 4266-4276 [PMID:19534531] |
ChEMBL | Inhibition of human ERG channel | B | 8.17 | pIC50 | 6.7 | nM | IC50 | J Med Chem (2009) 52: 4266-4276 [PMID:19534531] |
ChEMBL |